New film will address industry challenges and support efficient production of biopharmaceuticals
GE Healthcare’s Life Sciences business has agreed with Sealed Air Corporation, a global manufacturer of primary films for pharmaceutical solutions, to move to the next stage of a long-term partnership.
The two firms have created a new film suitable for applications across GE’s portfolio of single-use products.
Morgan Norris, GM of Upstream Products at GE Healthcare’s Life Sciences business, said the two firms 'share a vision of the importance of robust, high quality films in the efficient manufacture of life saving medicines such as monoclonal antibodies, vaccines and next generation biotherapeutics'.
Norris added: 'Through this partnership we are confident that we will deliver the next level of purposefully constructed and manufactured films for bioprocessing applications, enabling improved performance, supply chain control, and material/supplier transparency that the market demands of single-use suppliers.'
Gareth Crain, Vice President and General Manager of Sealed Air’s Medical Applications division added: 'This agreement provides a great platform for us to leverage our expertise in polymers, pharmaceutical regulatory and in-market requirements.'